Pyridazinediones deliver potent, stable, targeted and efficacious antibody–drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody

Abstract

Delivering potent, stable, targeted and<italic>in vivo</italic>efficacious antibody–drug conjugates (ADCs) using pyridazinedione functional disulfide re-bridging reagents.